Remove 2022 Remove Access Remove Safety
article thumbnail

Product Safety Recalls - Vape Cartridges

Americans for Safe Access

The issue of adulterants in cannabis vape products has once again resurfaced as the Pennsylvania Office of Medical Marijuana issued a notice to medical cannabis patients on February 4, 2022 advising them of a recall of over 500 different products containing substances not suitable for inhalation.

Vaping 240
article thumbnail

Press Release: MEDICAL MARIJUANA ACCESS AND PATIENT SAFETY, INC. ISSUES STATEMENT ON PENNSYLVANIA DEPARTMENT OF HEALTH’S WITHDRAWAL OF ITS APPEAL TO RECALL CERTAIN VAPORIZED MEDICAL MARIJUANA PRODUCTS

Cannabis Law Report

MEDICAL MARIJUANA ACCESS AND PATIENT SAFETY, INC. August 22, 2022 (Harrisburg, PA) — Medical Marijuana Access and Patient Safety, Inc. August 22, 2022 (Harrisburg, PA) — Medical Marijuana Access and Patient Safety, Inc. Click on image to access Docs.

Safety 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Analysis: Propagation of Cannabis Retailers Not Associated with Changes in Traffic Safety

Cannabis Law Report

POSTED ON AUGUST 18, 2022. A researcher affiliated with the University of California, San Diego examined county-level data from Colorado to assess the relationship between retail cannabis stores and trends in traffic safety. In this case, the net effect of expanding access to marijuana on traffic crashes could be quite small.

Safety 52
article thumbnail

Americans for Safe Access (ASA) has released a report examining the efficacy of state medical cannabis laws.

Cannabis Law Report

The organization has, they say, ……evaluated patient access, affordability, equity, and product safety. With a decline in legislative improvements in state medical cannabis programs, millions of patients are left with limited or no access,” ASA Executive Director Debbie Churgai said. “It Pennsylvania State Rep.

Access 98
article thumbnail

CBD Market Report

Project CBD

Despite the companies’ submitting the required data demonstrating the “reasonable expectation of safety under the recommended conditions of use,” the FDA rejected the applications, citing the drug preclusion clause. Accessed July 25, 2021. Available at: [link] Accessed October 17, 2022. Accessed October 17, 2022.

CBD 144
article thumbnail

Announcement: California Department of Cannabis Control Debuts Data Tool Showcasing Access Areas for Cannabis Business

Cannabis Law Report

This data helps Californians understand the work we have ahead of us in realizing the promises of cannabis legalization, including supporting access to a safe, legal, and equitable cannabis market across the state and combating the unregulated, illicit market”. — CA Department of Cannabis Control (@CAcannabisdept) May 26, 2022.

Data 52
article thumbnail

Manzuri Law – Their Top 10 of 2021 – Cannabis Law News and Soft Predictions for 2022

Cannabis Law Report

DCC needs to present a report to the Governor by July 1, 2022 that outlines the steps necessary for the incorporation of hemp products (and cannabis products with hemp cannabinoids) into the cannabis supply chain. 2022 brings four significant deadlines for California cannabis license applicants.

Law 98